Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) currently has a daily average trading volume of 28.51M but it saw 659278487 shares traded in last market. With a market cap of 35.51M USD, the company’s current market price of $0.19 came rising about 16.78 while comparing to the previous closing price of $0.16. In past 52 weeks, the stock remained buoying in the range of price level as high as $22.14 and as low as $0.12. In the recent trading on the day, stock has struck highest price mark of $0.1822 while lowest mark touched by it was $0.2763.
Taking a look at 20-day trading activity of Tonix Pharmaceuticals Holding Corp (TNXP) gives us an average price of $0.1501, while its current price level is -99.14% below from 52-week high level whereas it is 61.02% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1496 while that of 200 days or SMA-200 reads an average of $3.5865. A closer look into the stock’s movement over the week reveals that its volatility is standing at 20.57% during that period while stretching the period over a month that decreases to 12.58%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 64.53 which implies that the stock is in neutral territory.
ROTH Capital upgraded its recommendation for the stock as a “Buy” from “Neutral” on April 18, 2019 while assigning a price target of $4. ROTH Capital issued its recommendations for the stock as it upgraded the price target for the stock is $6.
Over the week, TNXP’s stock price is moving 34.56% up while it is 5.56% when we observe its performance for the past one month. Year-to-date it is -98.53% down and over the past year, the stock is showing a downside performance of -98.77%.
Currently, Tonix Pharmaceuticals Holding Corp’s total number of outstanding shares is 186.89M. Company’s return on investment (ROI) stands at -169.47% and return on equity (ROE) at -138.69%. Stock’s beta reads 2.18. Stock has a price to book (P/B) ratio of 0.40 while price to sale or P/S ratio amounts to 3.15. Its return on asset (ROA) is -115.46% on average.
